Olea europaea Linn (Oleaceae) Fruit Pulp Extract Suppresses Sterol Regulatory Element-Binding Proteins-1c via AMP-Activated Protein Kinase Activation in Human Hepatic Cells
نویسنده
چکیده
Purpose: To investigate the molecular mechanisms underlying the role of Olea europaea Linn (Oleaceae) fruit pulp extract (OPF) in the prevention of high glucose-induced lipid accumulation in human HepG2 hepatocytes. Methods: HepG2 cells were pretreated with various concentration of OPF (0, 10, 20, 40 and 80 μg/ml) and then treated with serum-free medium with normal glucose (5 mM) for 1 h, followed by exposure to high glucose (25 mM D-glucose) for 24 h. Cell viability and cytotoxicity parameters were measured using LDH and MTT assay while triglyceride and total cholesterol levels were evaluated using respective enzymatic reagent kits. Protein expressional levels were analyzed by Western blotting. Results: OPF did not influence the cell viability (up to 200 μg/ml) and showed any signs of cytotoxicity (up to 80 μg/ml). OPF significantly attenuated lipid accumulation in human HepG2 hepatocytes when exposed to high glucose (25 mM D-glucose) in a dose-dependently (p < 0.05, 0.01 and 0.001 at 20, 40 and 80 μg/ml concentrations, respectively). Nile red staining showed that 10, 20, 40 and 80 μg/ml concentrations of OPF reduced lipid accumulation by 25, 33.7 (p < 0.05), 43.7 (p < 0.01) and 52.5 % (p < 0.001), respectively. The increased levels of triglycerides and total cholesterol contents were also attenuated by OPF (p < 0.001 at 80 μg/ml). Further, OPF attenuated the expression of fatty acid synthase and sterol regulatory element-binding protein-1. Adenosine monophosphate-activated protein kinase was also activated by OPF treatment when exposed to high glucose (25 mM D-glucose) in human HepG2 hepatocytes. Conclusion: This study indicates that OPF has hypolipidemic effects by inhibiting lipid biosynthesis mediated via AMPK signaling. Thus, this extract can be potentially developed into an anti-obesity agent.
منابع مشابه
Nobiletin Inhibits Hepatic Lipogenesis via Activation of AMP-Activated Protein Kinase
We aimed to investigate the effects of nobiletin on hepatic lipogenesis in high glucose-induced lipid accumulation in HepG2 cells. Nobiletin, a citrus polymethoxyflavonoid with six methoxy groups, is present abundantly in the peels of citrus fruits. HepG2 cells were incubated in Dulbecco's modified Eagle's medium containing high glucose (25 mM) and subsequently treated with nobiletin at differe...
متن کاملMetformin attenuates palmitic acid-induced insulin resistance in L6 cells through the AMP-activated protein kinase/sterol regulatory element-binding protein-1c pathway.
AMP-activated protein kinase (AMPK) is an important effector of metformin action on glucose uptake in skeletal muscle cells. We recently reported that metformin improved insulin receptor substrate-1 (IRS-1)-associated insulin signaling by downregulating sterol regulatory element-binding protein-1c (SREBP-1c) expression. In this study, we investigated whether AMPK activation and SREBP-1c inhibit...
متن کاملAMP-activated protein kinase and hepatic genes involved in glucose metabolism.
Mammalian AMP-activated protein kinase presents strong structural and functional similarities with the yeast sucrose non-fermenting 1 (Snf1) kinase involved in the derepression of glucose-repressed genes. It is now clearly established that AMP-activated protein kinase in the liver decreases glycolytic/lipogenic gene expression as well as genes involved in hepatic glucose production. This is ach...
متن کاملProtein kinase Cbeta mediates hepatic induction of sterol-regulatory element binding protein-1c by insulin.
Sterol-regulatory element binding protein-1c (SREBP-1c) is a transcription factor that controls lipogenesis in the liver. Hepatic SREBP-1c is nutritionally regulated, and its sustained activation causes hepatic steatosis and insulin resistance. Although regulation of SREBP-1c is known to occur at the transcriptional level, the precise mechanism by which insulin signaling activates SREBP-1c prom...
متن کاملRimonabant, a cannabinoid receptor type 1 inverse agonist, inhibits hepatocyte lipogenesis by activating liver kinase B1 and AMP-activated protein kinase axis downstream of Gα i/o inhibition.
Liver X receptor-α (LXRα) and its target sterol regulatory element-binding protein-1c (SREBP-1c) play key roles in hepatic lipogenesis. Rimonabant, an inverse agonist of cannabinoid receptor type 1 (CB1), has been studied as an antiobesity drug. In view of the link between CB1 and energy metabolism, this study investigated the effect of rimonabant on LXRα-mediated lipogenesis in hepatocytes and...
متن کامل